DAIICHI SANKYO: Company report

Sun	Mon	Tue	Wed	Thu	Fri	Sat
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

Total Rating	Comment	Note
63	Excellent.	2013-03-31 Consolidated

Total Rating

Comment

Note

Excellent.

2013-03-31 Consolidated

Efficiency Rating	Profit Rating	Growth Rating	Scale Rating	Stability Rating
30	91	52	92	51

Efficiency Rating

Profit Rating

Growth Rating

Scale Rating

Stability Rating

DAIICHI SANKYO: Credit Rating (Bankruptcy Risk)

Rating	Comment	Note
BB	Credit is a little enough, but be insufficient potential by biz environs.	2013-03-31 Consolidated

Rating

Comment

Note

Credit is a little enough, but be insufficient potential by biz environs.

2013-03-31 Consolidated

*Detailed analysis is the following page of EDIUNET.

Company	EDINET Code	Ticker symbol	Market	Month	Industry
DAIICHI SANKYO	E00984	1303	TSE 1st	3	Chemicals

Company

EDINET Code

Ticker symbol

Market

Month

Industry

DAIICHI SANKYO

E00984

1303

TSE 1st

Chemicals

DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer - BioSpace

DATROWAY® Approved in the U.S. as First TROP2 Directed Therapy for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer BioSpace [2025/06/24]

AstraZeneca, Daiichi Sankyo gain lung cancer indication for Enhertu successor - Endpoints News

AstraZeneca, Daiichi Sankyo gain lung cancer indication for Enhertu successor Endpoints News [2025/06/24]

Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next. - BioPharma Dive

Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next. BioPharma Dive [2025/06/04]

At ASCO 2025, attendees see reason for hope, despite worries - STAT

At ASCO 2025, attendees see reason for hope, despite worries STAT [2025/05/30]

Daiichi Sankyo Company, Limited's (TSE:4568) P/E Is On The Mark - simplywall.st

Daiichi Sankyo Company, Limited's (TSE:4568) P/E Is On The Mark simplywall.st [2025/06/19]

Company	Rating
TAISHO PHARMACEU..	72
Otsuka Holdings	71
塩野義製薬	66

Company

Rating

TAISHO PHARMACEU..

Otsuka Holdings

塩野義製薬

DAIICHI SANKYO: Financial Rating

Rating Detail

DAIICHI SANKYO: Credit Rating (Bankruptcy Risk)

Company Information and Reputation powered by Googleニュース

Related Industry Ranking (*TOP 3)

Caution